DJIA 17,079.57 -42.44 -0.25%
NASDAQ 4,557.70 -11.93 -0.26%
S&P 500 1,996.74 -3.38 -0.17%
market minute promo

Pfizer (NYSE: PFE)

29.38 -0.11 (-0.37%)

REAL-TIME: Last trade at


company name or ticker

Recent Quotes

PFE $29.38 -0.37%
Company Photos
(Click to zoom)
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $29.43
Previous Close $29.49
Daily Range $29.36 - $29.67
52-Week Range $27.81 - $32.96
Market Cap $186.3B
P/E Ratio 18.55
Dividend (Yield) $1.04 (3.5%)
Ex-Dividend Date
Dividend Pay Date
07/30/14
09/03/14
Volume 20,582,183
Average Daily Volume 23,677,973
Current FY EPS $2.25

Sector

Healthcare

Industry

Drugs

Pfizer (PFE) Description

A research-based pharmaceutical company, Pfizer discovers, develops, manufactures, and markets prescription medicines such as Lipitor, Celebrex, and Viagra. Website: http://www.pfizer.com/

News & Commentary

3 Reasons for Rite Aid Corporation's Resurgence

Rite Aid's stock has soared nearly 500% in the last two years, but why?

UK Market Wrap: Tesco hits 11-year low, AstraZeneca climbs on renewed takeover talk

European Shares Slightly Up as Drug Makers Led by AstraZeneca Climb on Pfizer Takeover Talks

Sector Update: Health Care Stocks Mostly Lower; Regulators OK Expanded Use of Protalix Medication fo

Sector Update: Health Care Stocks Mostly Lower; Regulators OK Expanded Use of Protalix Medication for Gaucher Disease

Sector Update: Health Care

I Am Sure This Pharma-Company Suits Your Portfolio

UPDATE: Protalix Shares Spike Higher on FDA Approval of Pediatric Indication for ELELYSO(TM) for Inj

UPDATE: Protalix Shares Spike Higher on FDA Approval of Pediatric Indication for ELELYSO(TM) for Injection, for IV Use for Treatment of Type 1 Gaucher Disease

Higher Yielding Stocks With A Cheap EV/EBITDA Ratio And Low Debt Figures

Fast Money Picks For August 28

Growth Prospects Remain Strong For Pfizer

See More PFE News...

PFE's Top Competitors

PFE $29.38 (-0.37%)
Current stock: PFE
JNJ $102.95 (-0.26%)
Current stock: JNJ
ROG $60.00 (-0.18%)
Current stock: ROG
GSK $48.87 (0.41%)
Current stock: GSK